| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |